Literature DB >> 6280093

Differential effects of central adrenoceptor agonists on luteinizing hormone release.

P C Leung, G W Arendash, D I Whitmoyer, R A Gorski, C H Sawyer.   

Abstract

This study examined the alterations in episodic luteinizing hormone (LH) release in response to third ventricle infusions of various alpha- and beta-adrenoceptor agonists in ovariectomized (OVX) rats as well as the effects of steroid priming with 50 micrograms estradiol benzoate (EB) and 25 mg progesterone (P) on the LH responses to these agonists. Unanesthetized rats with indwelling atrial cannulae were bled at 10-min intervals for 0.5-1.5 h prior to infusion and up to 1.5 h following infusion of equimolar amounts (0.06 or 0.3 mumol in 2 microliters saline adjusted to pH 5.5 and infused slowly over a 2-min period) of norepinephrine (NE), phenylephrine (Phen, alpha 1-agonist), isoproterenol (Iso, beta-agonist) or clonidine (Clon, alpha 2-agonist). In unprimed OVX rats, 0.06 mumol NE induced a significant lengthening (by approximately 121%) of the episodic interval between the peak LH levels and caused a decrease in mean blood LH levels of approximately 24%, which began almost immediately and lasted for approximately 1 h after infusion. When administered in the same manner and dosage, both alpha- and beta-adrenergic agonists were similarly effective in suppressing pulsatile LH release in OVX unprimed rats, with the following rank order being apparent: Clon greater than NE congruent to Phen greater than Iso. However, in OVX-EBP-primed rats, while 0.06 mumol NE significantly stimulated LH release, none of the other adrenoceptor agonists administered at this dosage was effective in altering the low nonpulsatile levels of blood LH characteristic of the steroid-primed animal. Nevertheless, at a concentration 5 times higher (0.3 mumol) Clon and Phen did induce LH surges while Iso, even at this higher dose, was not stimulatory to LH release. These results suggest that the inhibitory action of NE on LH secretion in OVX rats may be exerted via activation of both alpha- and beta-adrenoceptors, whereas primarily alpha-adrenoceptors are responsible for mediating the NE-induced stimulation of LH release in OVX steroid-primed animals.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6280093     DOI: 10.1159/000123301

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  10 in total

1.  Correlative relationships between the specific binding of labeled adrenoligands in the brain and plasma testosterone in mice.

Authors:  G T Shishkina; E V Naumenko
Journal:  Neurosci Behav Physiol       Date:  1994 Sep-Oct

Review 2.  Amplitude and frequency modulation of pulsatile luteinizing hormone-releasing hormone release.

Authors:  J E Levine; P Chappell; L M Besecke; A C Bauer-Dantoin; A M Wolfe; T Porkka-Heiskanen; J H Urban
Journal:  Cell Mol Neurobiol       Date:  1995-02       Impact factor: 5.046

3.  Release of norepinephrine in the preoptic area activates anteroventral periventricular nucleus neurons and stimulates the surge of luteinizing hormone.

Authors:  Raphael E Szawka; Maristela O Poletini; Cristiane M Leite; Marcelo P Bernuci; Bruna Kalil; Leonardo B D Mendonça; Ruither O G Carolino; Cleyde V V Helena; Richard Bertram; Celso R Franci; Janete A Anselmo-Franci
Journal:  Endocrinology       Date:  2012-11-13       Impact factor: 4.736

4.  Estradiol enhances prostaglandin E2 receptor gene expression in luteinizing hormone-releasing hormone (LHRH) neurons and facilitates the LHRH response to PGE2 by activating a glia-to-neuron signaling pathway.

Authors:  F Rage; B J Lee; Y J Ma; S R Ojeda
Journal:  J Neurosci       Date:  1997-12-01       Impact factor: 6.167

5.  Norepinephrine suppresses gonadotropin-releasing hormone neuron excitability in the adult mouse.

Authors:  Seong-Kyu Han; Allan E Herbison
Journal:  Endocrinology       Date:  2007-12-13       Impact factor: 4.736

6.  Involvement of preoptic-anterior hypothalamic GABA neurons in the regulation of pituitary LH and prolactin release.

Authors:  R Lamberts; E Vijayan; M Graf; T Mansky; W Wuttke
Journal:  Exp Brain Res       Date:  1983       Impact factor: 1.972

7.  Catecholamines in hypothalamus, ovaries and uteri of rats with precocious puberty.

Authors:  O K Ivanisević-Milovanović; V Pantic; M Demajo; H Loncar-Stevanović
Journal:  J Endocrinol Invest       Date:  1993-11       Impact factor: 4.256

8.  Effect of ventral noradrenergic bundle lesions on concentrations of monoamine neurotransmitters and metabolites in several discrete areas of the rat brain.

Authors:  C A Johnston; L A Mattiace; A Negro-Vilar
Journal:  Cell Mol Neurobiol       Date:  1987-12       Impact factor: 5.046

9.  Beyond Leptin: Emerging Candidates for the Integration of Metabolic and Reproductive Function during Negative Energy Balance.

Authors:  Cadence True; Kevin L Grove; M Susan Smith
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-17       Impact factor: 5.555

10.  GnRH dysregulation in polycystic ovarian syndrome (PCOS) is a manifestation of an altered neurotransmitter profile.

Authors:  Nirja Chaudhari; Mitali Dawalbhakta; Laxmipriya Nampoothiri
Journal:  Reprod Biol Endocrinol       Date:  2018-04-11       Impact factor: 5.211

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.